NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+8.51%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.11B
AUM Growth
+$1.11B
(+8.6%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
128
New
18
Increased
18
Reduced
46
Closed
17
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$107M |
| 2 |
Hilton Grand Vacations
HGV
|
$15.9M |
| 3 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$8.1M |
| 4 |
Bioventus
BVS
|
$7.28M |
| 5 |
Payoneer
PAYO
|
$4.94M |
Top Sells
| 1 |
Costco
COST
|
$40.9M |
| 2 |
Light & Wonder
LNW
|
$29.8M |
| 3 |
DXP Enterprises
DXPE
|
$22.7M |
| 4 |
MillerKnoll
MLKN
|
$11.8M |
| 5 |
Travel + Leisure Co
TNL
|
$10.8M |
Sector Composition
| 1 | Healthcare | 44.5% |
| 2 | Consumer Discretionary | 15.38% |
| 3 | Industrials | 7.43% |
| 4 | Financials | 6.27% |
| 5 | Technology | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MediaAlpha
MAX
$596M
| $12.8M | 0.83% | 1,283,240 -275,268 | -18% | -$2.74M |
|
27
DarioHealth
DRIO
$22.8M
| $10.6M | 0.68% | 2,466,757 +271,384 | +12% | +$1.16M |
|
|
AMYT
28
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $10.5M | 0.68% | 1,437,458 | – | – |
|
|
CNCE
29
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $10.1M | 0.66% | 1,732,388 -54,771 | -3% | -$320K |
|
|
RDNW
30
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $9.64M | 0.62% | 1,489,391 +1,252,416 | +529% | +$8.1M |
|
|
31
DXP Enterprises
DXPE
$1.96B
| $9.31M | 0.6% | 338,090 -823,190 | -71% | -$22.7M |
|
32
Aura Biosciences
AURA
$389M
| $8.39M | 0.54% | 798,751 +414,987 | +108% | +$4.36M |
|
|
33
Bioventus
BVS
$495M
| $8.27M | 0.54% | 3,168,574 +2,789,735 | +736% | +$7.28M |
|
34
Reading International Class A
RDI
$35M
| $8.05M | 0.52% | 2,907,774 -8,801 | -0.3% | -$24.4K |
|
35
RH
RH
$4.23B
| $7.69M | 0.5% | 28,797 -26,872 | -48% | -$7.18M |
|
|
36
Payoneer
PAYO
$2.5B
| $7.66M | 0.5% | 1,084,831 +699,465 | +182% | +$4.94M |
|
37
Lyra Therapeutics
LYRA
$11.5M
| $6.97M | 0.45% | 2,220,830 -25,000 | -1% | -$78.5K |
|
38
Taysha Gene Therapies
TSHA
$797M
| $6.78M | 0.44% | 2,999,765 +1,388,943 | +86% | +$3.14M |
|
39
Fortress Biotech
FBIO
$76.8M
| $5.22M | 0.34% | 7,968,056 -294,996 | -4% | -$193K |
|
40
Ventyx Biosciences
VTYX
$171M
| $5.18M | 0.34% | 158,033 +41,400 | +35% | +$1.36M |
|
41
Perella Weinberg Partners
PWP
$1.38B
| $4.94M | 0.32% | 239,819 -265,474 | -53% | -$5.47M |
|
42
RingCentral
RNG
$2.76B
| $4.87M | 0.32% | 137,622 -30,000 | -18% | -$1.06M |
|
43
IDEAYA Biosciences
IDYA
$2.15B
| $4.61M | 0.3% | 253,480 | – | – |
|
44
Abeona Therapeutics
ABEO
$350M
| $4.19M | 0.27% | +272,731 | New | +$4.19M |
|
|
PNT
45
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $4.17M | 0.27% | 572,191 +374,408 | +189% | +$2.73M |
|
|
WEBR
46
DELISTED
Weber Inc.
WEBR
| $4.03M | 0.26% | +500,000 | New | +$4.03M |
|
47
TELA Bio
TELA
$70.5M
| $4.01M | 0.26% | 349,002 | – | – |
|
48
Fulcrum Therapeutics
FULC
$351M
| $3.64M | 0.24% | +500,000 | New | +$3.64M |
|
|
APTO
49
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.51M | 0.23% | 6,052,867 -835,955 | -12% | -$485K |
|
50
Strata Skin Sciences
SSKN
$9.93M
| $3.47M | 0.23% | 4,393,685 | – | – |
|